8 news items
JMP Securities Maintains Market Outperform on Paragon 28, Lowers Price Target to $20
FNA
9 May 24
JMP Securities analyst David Turkaly maintains Paragon 28 (NYSE:FNA) with a Market Outperform and lowers the price target from $23 to $20.
What Analysts Are Saying About Paragon 28 Stock
FNA
9 May 24
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $16.57, along
Piper Sandler Reiterates Overweight on Paragon 28, Lowers Price Target to $15
FNA
9 May 24
Piper Sandler analyst Matt O'Brien reiterates Paragon 28 (NYSE:FNA) with a Overweight and lowers the price target from $18 to $15.
Needham Maintains Buy on Paragon 28, Lowers Price Target to $14
FNA
9 May 24
Needham analyst Mike Matson maintains Paragon 28 (NYSE:FNA) with a Buy and lowers the price target from $17 to $14.
Stephens & Co. Reiterates Overweight on Paragon 28, Maintains $18 Price Target
FNA
5 Apr 24
Stephens & Co. analyst George Sellers reiterates Paragon 28 (NYSE:FNA) with a Overweight and maintains $18 price target.
8acgfftaxhb4e8w9vj7
FNA
4 Apr 24
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $17.25, a high estimate
dacg3nx l7u8n6s2mq41adsz
FNA
4 Apr 24
Needham analyst Mike Matson reiterates Paragon 28 (NYSE:FNA) with a Buy and maintains $17 price target.
961avl9v hskpgat74t24u0c0yv0zf84xpmq79r4q5babx56xca
ALPN
AQST
FAAS
4 Apr 24
after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $8 to $7.
Alpine Immune Sciences
- Prev
- 1
- Next